Evolent Health (EVH) Current Deferred Revenue (2015 - 2026)

Evolent Health's Current Deferred Revenue history runs 12 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• On a quarterly basis, Current Deferred Revenue fell 71.76% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 71.76% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, down 52.01% from the prior year.
• Current Deferred Revenue grew to $1.4 million in Q1 2026 per EVH's latest filing, from $1.2 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $17.3 million in Q1 2022 and bottomed at $1.2 million in Q4 2025.
• The 5-year median for Current Deferred Revenue is $5.8 million (2022), against an average of $6.2 million.
• Across the five-year window, Current Deferred Revenue grew 29.48% in 2022 and slumped 71.76% in 2026, its largest moves.
• Year by year, Current Deferred Revenue stood at $5.8 million in 2022, then grew by 24.16% to $7.1 million in 2023, then tumbled by 64.93% to $2.5 million in 2024, then tumbled by 52.01% to $1.2 million in 2025, then advanced by 17.79% to $1.4 million in 2026.
• Per Business Quant, the three latest EVH Current Deferred Revenue figures stand at $1.4 million (Q1 2026), $1.2 million (Q4 2025), and $2.1 million (Q3 2025).